TNF and rheumatoid arthritis: Several studies involving the use of anti-TNFα agents, including our previous observations (31), have already shown that the reduction in the number of sublining macrophages from baseline, also at early time-points after starting the treatment, associated with clinical response in RA (32, 33); we have here further confirmed this evidence.